home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  December 08, 2019
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 525 active entries

Preferred Cell Systems™

1485 Garden of the Gods Road, Suite 152
Colorado Springs, 80907
United States of America, Colorado

Phone: (719) 264-6251
Fax: (719) 264-6253

Description:

Preferred Cell Systems™ develops innovative, high-quality in vitro assays and cell culture media for the life science community. Our products have been designed for the following applications:


 

  • CELLULAR THERAPY:

Hematopoietic Stem Cell Therapy Products: Colony-Forming Assays (CFC), CFU-Equivalent, Viability, Quality Control, Potency, Patient Monitoring and More.

 

  • STEM CELL RESEARCH:

Assays and Media for Hematopoietic Stem Cells, MSC's, Immune Cells, ES, iPS, Primary Explanted Stem Cells, Cell Lines and Cancer Stem Cells. 

 

  • IN VITRO TOXICOLOGY:

Bone Marrow Toxicity/Stem Cell Hematotoxicity, Immunotoxicity, Hepatotoxicity, Neurotoxicity, MSC, iPS, ES Toxicity Assays and More. 

 

  • REGENERATIVE MEDICINE:

Mesenchymal Stem Cells, iPS and ES Products: Quality Control and Potency Assays, MSCGro Medium, Human Platelet Lysate.

 

Preferred Cell Systems™ is the exclusive manufacturer and supplier of all reagents and in vitro assays originally produced by HemoGenix. We are fully committed and guarantee the highest quality of products and customer services. For contract services, please visit the HemoGenix website: www.hemogenix.com



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Diagnostics
- in vitro
Pharmaceutical
- Research
Supplier
- Research

Last update of this entry: August 28, 2019

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.